COC(=O)[C@@H]1[C@H](c2cccc(C(F)(F)F)c2)NC(=O)N(Cc2ccccc2)[C@@H]1C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?